Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.43% | 203.20 | 1.2% | $410.88m | |
| GILD | Gilead Sciences, Inc. | 0.29% | 73.88 | 0.9% | $388.27m | |
| CELG | Celgene Corporation | -0.26% | 87.38 | 1.2% | $331.13m | |
| BIIB | Biogen Inc. | 0.60% | 338.91 | 1.2% | $285.04m | |
| ILMN | Illumina, Inc. | -0.15% | 350.37 | 3.5% | $238.24m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.19% | 383.70 | 2.6% | $211.99m | |
| EXAS | Exact Sciences Corporation | 1.90% | 74.14 | 25.3% | $196.59m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.29% | 176.60 | 1.9% | $158.10m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.06% | 151.95 | 16.4% | $124.69m | |
| A | Agilent Technologies, Inc. | 0.93% | 69.57 | 1.5% | $120.73m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.95% | 121.97 | 2.0% | $110.07m | |
| VKTX | Viking Therapeutics, Inc. | 0.98% | 19.65 | 0.9% | $100.12m | |
| NKTR | Nektar Therapeutics | -2.81% | 56.69 | 5.6% | $93.69m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 1.14% | 94.82 | 9.7% | $93.23m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.21% | 99.77 | 4.4% | $92.72m |
Company Profile
Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engages in finding treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded on January 27, 2000 and is headquartered in Wayne, PA.